BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Dev California Life Sciences - ECPv6.1.2.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Dev California Life Sciences
X-ORIGINAL-URL:https://dev.califesciences.org
X-WR-CALDESC:Events for Dev California Life Sciences
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220526T080000
DTEND;TZID=America/Los_Angeles:20220526T190000
DTSTAMP:20260407T094024
CREATED:20220506T154927Z
LAST-MODIFIED:20220506T155007Z
UID:8403-1653552000-1653591600@dev.califesciences.org
SUMMARY:LABEST - Los Angeles Bioscience Ecosystem Summit
DESCRIPTION:LABEST – Los Angeles Bioscience Ecosystem Summit 2022 is the premier showcase for bioscience innovation in Los Angeles County produced by UCLA TDG (Technology Development Group) – the tech transfer office for the University. This event is a collaboration with colleagues from across the county to present promising academic research\, entrepreneurial faculty investigators\, as well as local incubators and start up companies. It is intended to promote awareness of the growing life science entrepreneurial ecosystem in Los Angeles and to foster partnerships with the biotechnology and life science industry. \nThroughout the day\, faculty members present their latest scientific breakthroughs\, which will lead to the critical therapies of tomorrow. Leading bioscience translational research programs and start ups will be showcased where Southern California Institutions have significant expertise\, pioneering research and resource commitments directed towards developing innovative patient therapies. \nRegister» \n1) MAIN TRACK –  Exciting panels with the current leaders of bioscience \nVIEW MAIN TRACK AGENDA (PDF)   \n  \n2) LOS ANGELES INCUBATOR SHOWCASE by The Lundquist Institute and Sponsored by SMBC – Six Los Angeles area Incubators will bring in the best of their residing start ups to fast pitch \nVIEW LA INCUBATOR SHOWCASE AGENDA (PDF)    \n  \n3) UCLA RESEARCH SHOWCASES – UCLA’s eight Unified Research Themes are organizing interactive sessions to showcase research programs\, translational faculty\, successful biopharma collaborations and startups. \nVIEW UCLA RESEARCH SHOWCASE AGENDA (PDF) \n     SHOWCASE A \n10:05 AM Metabolism of Aging and Cancer & Metabolism     \n11:10 AM Neuroscience Breakthroughs: From Molecules to Patients \n1:50 PM   Introduction to HETSS – Health Equity Translational Social Science \n3:00 PM   Precision Health \n SHOWCASE B \n10:05 AM The Global Reach of I3T Research: Innovation for Current and Emerging Infections \n11:10 AM Cardiovascular Innovation \n1:45 PM  Cancer: Immuno-Oncology \n3:30 PM  Regenerative Medicine \n  \n4) NUCLEATE | UCLA PDA PROGRAM for LIFE SCIENCE ENTREPRENEURS – a custom educational track designed especially for Post Docs and Graduate Students featuring seven student teams who will fast pitch as well as workshops for budding life science entrepreneurs. This track includes a special lunch with a panel on Diversity\, Equity and Inclusion Strategies for Recruitment and Retention in Life Science. Recruitment reps from local pharma and other companies will be participating! \nNUCLEATE UCLA PDA AGENDA (PDF) \n  \nPEARL COHEN POSTER AWARD COMPETITION \nUCLA TDG is currently accepting submissions for the Pearl Cohen Poster Award Competition ($250 – $750 cash prizes) which is a unique opportunity to showcase your bioscience research programs in front of pharma and biotech industry leaders. All accepted submissions will be displayed during digital “Poster Plaza Session”\, arranged by therapeutic area\, with three presentation timeslots (complimentary admission included for the lead author).  Award winners will be announced during the event.  See Details \nPEARL COHEN POSTER ENTRY DETAILS \n  \nIf you have any questions\, please email us at labest@tdg.ucla.edu . \n  \n 
URL:https://dev.califesciences.org/event/la-best-la-bioscience-ecosystem/
CATEGORIES:Industry Collaboration & Networking,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-15.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220524T110000
DTEND;TZID=America/New_York:20220524T160000
DTSTAMP:20260407T094024
CREATED:20220411T183212Z
LAST-MODIFIED:20220411T204606Z
UID:7411-1653390000-1653408000@dev.califesciences.org
SUMMARY:Fierce Pharma: Leaders in Life Sciences Forum
DESCRIPTION:Location: Virtual \n  \nThe Fierce Leaders in Life Sciences Forum brings together forward-thinking minds from today’s life sciences industry and features insights from C-suite and executive leadership on the end-to-end drug development process\, highlighting innovative approaches in today’s evolving healthcare landscape to conducting: \n\nR&D and translational science\nClinical development\nProduct commercialization\n\nTop Reasons to Attend\n\nIndustry Updates: Hear from biotech and big pharma executives on emerging trends and market dynamics\nGain Tactics for Better Collaboration: Hear best practices on connecting R&D and clinical teams to the commercials teams to develop an appropriate timeline and practice approach to bring a new product to launch\nLearn How to Plan: Understand how to develop a cohesive brand launch strategy with marketing communication that is effective and tailored to the needs of the regional associates\nStay Ahead of Current Trends: Learn how best to utilize competitive intelligence and market research throughout the launch process to validate ideas and identify potential for greater success\nNetworking Opportunities: Connect with senior leadership in the life sciences industry to gain insights and share best practices on daily challenges faced\n\n  \n \n  \nRegister» \n  \n 
URL:https://dev.califesciences.org/event/fierce-pharma-leaders-in-life-sciences-forum/
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/03/258762_CLS_22_Event_Graphics-13-450x254-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220519T150000
DTEND;TZID=America/Los_Angeles:20220519T170000
DTSTAMP:20260407T094024
CREATED:20220512T214355Z
LAST-MODIFIED:20220512T214355Z
UID:8698-1652972400-1652979600@dev.califesciences.org
SUMMARY:Health Equity Forum: A Discussion on Clinical Trials Black Community – Our Past\, Present\, and Future
DESCRIPTION:Join CBHN for a conversation with Jeri Lacks and David Lacks III\, of the Henrietta Lacks Family\, about their grandmother’s legacy\, what the family has done over the years to ensure greater protection for patients in clinical trials\, and the Henrietta Lacks Enhancing Cancer Research Act of 2019 and what it means in addressing health disparities. \n  \nRegister»
URL:https://dev.califesciences.org/event/health-equity-forum-a-discussion-on-clinical-trials-black-community-our-past-present-and-future/
CATEGORIES:Community Initiatives & Programs,Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-15.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220519T090000
DTEND;TZID=America/Los_Angeles:20220519T100000
DTSTAMP:20260407T094024
CREATED:20220419T200521Z
LAST-MODIFIED:20220420T155511Z
UID:8080-1652950800-1652954400@dev.califesciences.org
SUMMARY:IQVIA - Critical Success Factors For Commercialization - Innovative Customer Engagement Models
DESCRIPTION:The number of biopharma and biotech companies developing and launching new therapies is continuing to rise with emerging biopharma remaining a strong source of innovation. At the same time\, more barriers to success are emerging with requirements for increasingly complex clinical trials\, continuous regulatory changes\, evolving payer conditions\, and more restrictive access to HCPs. \nIt’s evident that asset success starts early\, with a need to ensure evidence generation delivers endpoints that demonstrate value to regulators\, payers\, prescribers\, and patients. Communicating that value requires an adaptable\, omnichannel approach to activate and engage all stakeholders for launch and throughout the product lifecycle. \nLearn how IQVIA is helping clinical and commercial customers bring therapies to market and to the patients who need them. \nIQVIA experts will break down the components of successful commercialization for emerging biopharma and biotech companies. \nInnovative Customer Engagement Models \nWhile the value of face-to-face\, personal HCP interactions remain impactful\, the efficacy\, adoption\, and ROI of digital\, non-personal engagement continues to increase. IQVIA experts will discuss the imperatives for an agile and flexible engagement model for emerging biopharma; one that’s fit for today’s realities while being ready for what tomorrow will bring. \nRegister» \nAsk the experts \nIQVIA experts will take your questions at the end of each session. If they are unable to address every question live\, they will follow up with an answer individually to ensure you have the information you need.
URL:https://dev.califesciences.org/event/iqvia-critical-success-factors-for-commercialization-innovative-customer-engagement-models/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220519
DTEND;VALUE=DATE:20220521
DTSTAMP:20260407T094024
CREATED:20220224T233602Z
LAST-MODIFIED:20220331T210524Z
UID:6640-1652918400-1653091199@dev.califesciences.org
SUMMARY:Personalized Medicine Coalition: 16th Annual Personalized Medicine Conference
DESCRIPTION:Location: Dana Point\, CA \n  \nConvening more than 500 of the world’s leading clinicians\, industry executives\, investors\, patient advocates\, payers\, policy experts\, and researchers\, the 16th Annual Personalized Medicine Conference will facilitate a cross-sector exchange of perspectives on the scientific\, business\, and policy issues influencing the status and outlook for personalized medicine in the wake of a devastating pandemic that has upended the health care landscape. Participants will help chart a course toward a brighter future for patients and health systems. \nTo stay up-to-date about the conference and related issues in personalized medicine\, click here to join the Personalized Medicine Coalition’s mailing list. \n  \nRegister» \n 
URL:https://dev.califesciences.org/event/personalized-medicine-coalition-16th-annual-personalized-medicine-conference/
LOCATION:Ritz-Carlton Laguna Niguel\, Dana Point\, CA\, Dana Point\, United States
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220518T090000
DTEND;TZID=America/Los_Angeles:20220518T120000
DTSTAMP:20260407T094024
CREATED:20220419T200018Z
LAST-MODIFIED:20220420T163902Z
UID:8078-1652864400-1652875200@dev.califesciences.org
SUMMARY:IQVIA – Critical Success Factors For Commercialization Series – Asset Success Starts Early: Demonstrating and Communicating the Value of Your Therapy
DESCRIPTION:The number of biopharma and biotech companies developing and launching new therapies is continuing to rise with emerging biopharma remaining a strong source of innovation. At the same time\, more barriers to success are emerging with requirements for increasingly complex clinical trials\, continuous regulatory changes\, evolving payer conditions\, and more restrictive access to HCPs. \nIt’s evident that asset success starts early\, with a need to ensure evidence generation delivers endpoints that demonstrate value to regulators\, payers\, prescribers\, and patients. Communicating that value requires an adaptable\, omnichannel approach to activate and engage all stakeholders for launch and throughout the product lifecycle. \nLearn how IQVIA is helping clinical and commercial customers bring therapies to market and to the patients who need them. \nIQVIA experts will break down the components of successful commercialization for emerging biopharma and biotech companies. \nAsset Success Starts Early: Demonstrating and Communicating the Value of Your Therapy \nIQVIA experts will share perspectives on how emerging biopharma companies can demonstrate and communicate the value of new therapies by engaging thought leaders to ensure their innovation reaches the patients who need it. \nRegister» \nAsk the experts \nIQVIA experts will take your questions at the end of each session. If they are unable to address every question live\, they will follow up with an answer individually to ensure you have the information you need.
URL:https://dev.califesciences.org/event/iqvia-critical-success-factors-for-commercialization-series-asset-success-starts-early-demonstrating-and-communicating-the-value-of-your-therapy/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220517T170000
DTEND;TZID=America/Los_Angeles:20220517T180000
DTSTAMP:20260407T094024
CREATED:20220427T180528Z
LAST-MODIFIED:20220427T180528Z
UID:8270-1652806800-1652810400@dev.califesciences.org
SUMMARY:2022 ACS CAN California Policy Roundtable and Awards Event
DESCRIPTION:The Registry is a comprehensive state-wide cancer surveillance program that collects information on cancers diagnosed in California and provides insight to develop strategies and policies for cancer prevention\, treatment\, and control to promote health equity among Californians living with cancer. \nWe will also honor State Senator Susan Rubio and Assemblymember Mike Gipson for championing legislation on behalf of cancer patients\, caregivers\, and their families. \nRegister»
URL:https://dev.califesciences.org/event/2022-acs-can-california-policy-roundtable-and-awards-event/
CATEGORIES:Industry Supported,Member Events
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/03/258762_CLS_22_Event_Graphics-13-450x254-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220512T090000
DTEND;TZID=America/Los_Angeles:20220512T100000
DTSTAMP:20260407T094024
CREATED:20220419T195644Z
LAST-MODIFIED:20220420T154527Z
UID:8076-1652346000-1652349600@dev.califesciences.org
SUMMARY:IQVIA - Critical Success Factors For Commercialization Series - Preparing to Enter the Market: A Focus on Market Access
DESCRIPTION:The number of biopharma and biotech companies developing and launching new therapies is continuing to rise with emerging biopharma remaining a strong source of innovation. At the same time\, more barriers to success are emerging with requirements for increasingly complex clinical trials\, continuous regulatory changes\, evolving payer conditions\, and more restrictive access to HCPs. \nIt’s evident that asset success starts early\, with a need to ensure evidence generation delivers endpoints that demonstrate value to regulators\, payers\, prescribers\, and patients. Communicating that value requires an adaptable\, omnichannel approach to activate and engage all stakeholders for launch and throughout the product lifecycle. \nLearn how IQVIA is helping clinical and commercial customers bring therapies to market and to the patients who need them. \nIQVIA experts will break down the components of successful commercialization for emerging biopharma and biotech companies. \nPreparing to Enter the Market: A Focus on Market Access \nAsset success relies on strong engagement with the key stakeholders who will influence the path to the patient. Learn from IQVIA experts as they share key considerations for emerging biopharma companies who need to establish market access in the U.S. \nRegister» \nAsk the experts \nIQVIA experts will take your questions at the end of each session. If they are unable to address every question live\, they will follow up with an answer individually to ensure you have the information you need.
URL:https://dev.califesciences.org/event/iqvia-critical-success-factors-for-commercialization-series-preparing-to-enter-the-market-a-focus-on-market-access/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220511T090000
DTEND;TZID=America/New_York:20220511T130000
DTSTAMP:20260407T094024
CREATED:20220325T193143Z
LAST-MODIFIED:20220420T155633Z
UID:7032-1652259600-1652274000@dev.califesciences.org
SUMMARY:Public Health & Its Access to Historically Excluded Communities\, Pt. 2 "Othering" People
DESCRIPTION:In jurisdictions as large and diverse as California\, the understanding of health equity and how to apply best practices could not be more pressing. Improving and assuring racial equity above racial equality has been shown to reduce inequity in healthcare outcomes through community-level investment\, equitable leadership development\, and most importantly increased access to timely and culturally responsive healthcare and treatment. Please join Ace Robinson\, California Life Sciences\, and Center for Excellence in Nonprofits for this four-part series exploring these topics. Participants will leave with a customized playbook on how to increase access and improve health outcomes for historically excluded communities. \nRegister»
URL:https://dev.califesciences.org/event/public-health-its-access-to-historically-excluded-communities/
LOCATION:Virtual
CATEGORIES:Industry Collaboration & Networking,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-12.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220511T090000
DTEND;TZID=America/Los_Angeles:20220511T100000
DTSTAMP:20260407T094024
CREATED:20220419T193126Z
LAST-MODIFIED:20220420T155241Z
UID:8070-1652259600-1652263200@dev.califesciences.org
SUMMARY:IQVIA - Critical Success Factors For Commercialization Series - Emerging Biopharma Prevailing Trends
DESCRIPTION:The number of biopharma and biotech companies developing and launching new therapies is continuing to rise with emerging biopharma remaining a strong source of innovation. At the same time\, more barriers to success are emerging with requirements for increasingly complex clinical trials\, continuous regulatory changes\, evolving payer conditions\, and more restrictive access to HCPs. \nIt’s evident that asset success starts early\, with a need to ensure evidence generation delivers endpoints that demonstrate value to regulators\, payers\, prescribers\, and patients. Communicating that value requires an adaptable\, omnichannel approach to activate and engage all stakeholders for launch and throughout the product lifecycle. \nLearn how IQVIA is helping clinical and commercial customers bring therapies to market and to the patients who need them. \nIQVIA experts will break down the components of successful commercialization for emerging biopharma and biotech companies. \nEmerging Biopharma Prevailing Trends \nHear key insights from the recently published IQVIA Institute report on the contribution of emerging biopharma to development and commercialization\, as well as prevailing commercial launch trends and the implications for a successful asset strategy. \nRegister» \nAsk the experts \nIQVIA experts will take your questions at the end of each session. If they are unable to address every question live\, they will follow up with an answer individually to ensure you have the information you need.
URL:https://dev.califesciences.org/event/iqvia-critical-success-factors-for-commercialization/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220504T100000
DTEND;TZID=America/Los_Angeles:20220504T110000
DTSTAMP:20260407T094024
CREATED:20220420T180350Z
LAST-MODIFIED:20220420T180450Z
UID:8097-1651658400-1651662000@dev.califesciences.org
SUMMARY:Copyright at Work
DESCRIPTION:If you’ve ever been puzzled by copyright questions\, don’t miss this opportunity to learn from the copyright experts and to expand your respect for intellectual property. Not only will you get answers to your copyright questions\, but you’ll also learn how to minimize your company’s exposure to illegal content use. Please join us for this engaging and educational webcast. \nThis session features: \n\nThe basics of copyright law\nWhat is and what is not copyright protected\nFair use – what it is and how it works\nWhen copyright permission is needed\, for both photocopies and electronic content\nHow to obtain copyright permission and much more…\n\nRegister»
URL:https://dev.califesciences.org/event/copyright-at-work/
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220503T130000
DTEND;TZID=America/Los_Angeles:20220503T160000
DTSTAMP:20260407T094024
CREATED:20220427T163454Z
LAST-MODIFIED:20220427T180520Z
UID:8260-1651582800-1651593600@dev.califesciences.org
SUMMARY:USC - Grand Opening of Three Research Facilities At Michelson Center
DESCRIPTION:Grand Opening of Three Research Facilities @ USC Michelson Center\n\n\n\n\n\n\n\nDean Yannis Yortsos and Dean Amber Miller invite you to the Grand Opening of three state-of-the-art research facilities at the USC Michelson Center for Convergent Bioscience on Tuesday\, May 3rd\, 2022 from 1-4pm. \nHosted by: USC Viterbi School of Engineering and USC Dornsife College of Letters\, Arts and Sciences \nInterdisciplinary research conducted in these facilities is applicable to a variety of industries\, including biotech/biopharma\, aerospace\, advanced materials\, and semiconductor manufacturing. These core facilities enable a thriving research ecosystem; they are open to all members of the USC community and are available to external users. \nAgenda: \n\n1:00pm – Check-In\n1:30pm – Welcome by Deans of Viterbi & Dornsife\n1:45pm – Overview of the three facilities by Directors\n2:00pm – Graduate Research Poster Symposium\, Facility Tours\, and Reception\n\nRegister» \nHosted parking will be available for all guests
URL:https://dev.califesciences.org/event/usc-grand-opening-of-three-research-facilities-at-michelson-center/
LOCATION:USC Michelson Center for Convergent Bioscience\, 1002 Childs Way\, Los Angeles\, CA\, 90089\, United States
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/03/258762_CLS_22_Event_Graphics-13-450x254-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220426T080000
DTEND;TZID=America/Los_Angeles:20220428T110000
DTSTAMP:20260407T094024
CREATED:20220415T170625Z
LAST-MODIFIED:20220420T152935Z
UID:7985-1650960000-1651143600@dev.califesciences.org
SUMMARY:WuXi Healthcare Forum 2022 - Call To Action
DESCRIPTION:We are delighted to share with you the full agenda below for the WuXi Healthcare Forum 2022\, taking place virtually on April 26-28. More than 50 distinguished global leaders will be speaking at this year’s forum\, where thousands of colleagues from around the world will unite once again under this year’s theme\, “Call To Action\,” to support the World Health Organization’s key initiatives in tackling global health challenges head-on\, and to collaboratively advance better healthcare solutions. \n  \n \n  \nComplimentary and open to the global healthcare innovation ecosystem\, this 3-day program will premiere via Zoom from 8am-11am PDT (11am-2pm EDT) daily from April 26-28. To accommodate our global audience\, all registrants will be provided with a link to the on-demand recording of this event. Please log on https://bit.ly/3ucMOgt to register this event and log on https://bit.ly/3jL4Oc5 for speaker bios and program updates. \n  \nAGENDA (The times below are AM\, Pacific Daylight Time | Virtual via Zoom) \n  \nDay 1\, April 26 \n8:00 Welcome & Opening Remarks \nHui Cai\, Program Chair\, VP & Head of Content\, WuXi AppTec Steve Yang\, Co-CEO\, WuXi AppTec \n8:10 Chronic Diseases: Rising to the Challenge A conversation between Sir Menelas Pangalos\, EVP & President\, BioPharmaceuticals R&D\, AstraZeneca\, and Steve Yang\, Co-CEO\, WuXi AppTec \n8:30 Global Health: From Partnership to Worldwide Access A conversation between Emilio Emini\, CEO\, Bill & Melinda Gates Medical Research Institute\, and Zina Affas Besse\, Deputy Head\, Healthcare Private Equity\, AXA Investment Managers Group \n8:50 Call to Action: The Neuro Challenge Walter Koroshetz\, Director\, National Institute of Neurological Disorders & Stroke\, National Institutes of Health \n9:10 Call to Action: The Cardiovascular Challenge A conversation between Mariell Jessup\, Chief Science & Medical Officer\, American Heart Association\, and Faiez Zannad\, Emeritus Professor of Therapeutics & Cardiology\, Université de Lorraine\, Inserm; Chairman\, CVCT\, Paris\, France \n9:35 Call to Action: The Cancer Challenge A conversation between Harold Burstein\, Institute Physician\, Dana-Farber Cancer Institute; Professor of Medicine\, Harvard Medical School\, Arif Kamal\, Chief Patient Officer\, American Cancer Society; Physician Quality & Outcomes Officer\, Duke Cancer Institute\, and Tony Mok\, Li Shu Fan Professor of Clinical Oncology\, The Chinese University of Hong Kong \n10:10 Spotlight on Antimicrobial Resistance Erin Duffy\, Chief of Research & Development\, CARB-X Valeria Gigante\, Team Lead\, AMR Division\, World Health Organization\, Geneva\, Switzerland Timothy Jinks\, Head of Infectious Diseases Interventions\, The Wellcome Trust Henry Skinner\, CEO\, AMR Action Fund Session Leader: Jenny Yip\, Managing Partner\, Adjuvant Capital \n11:00 Day 1 Adjourn \nDay 2\, April 27 \n8:00 Welcome & Opening Remarks \nRichard Soll\, Head of Boston Office & Senior Advisor of Strategic Projects\, WuXi AppTec Minzhang Chen\, Co-CEO\, WuXi AppTec \n8:10 Better. Faster. Smarter. \nStephen Hahn\, CEO-Partner\, Flagship Pioneering; CEO\, Harbinger Health \n8:30 Moving the Needle on Neurological Disorders Laurence Barker\, Partner\, The Dementia Discovery Fund Christina Isacson\, Partner\, Lightstone Ventures Philip Scheltens\, Head\, Dementia Fund\, EQT Life Sciences Session Leader: Rana Al-Hallaq\, Partner\, Pfizer Ventures \n9:05 Spotlight on Parkinson’s Disease \nA conversation between Todd Sherer\, EVP\, Research Strategy\, The Michael J. Fox Foundation for Parkinson’s Research\, and Andrew Siderowf\, Hurtig-Stern Professor in Neurology\, University of Pennsylvania Perelman School of Medicine \n9:30 Revitalizing Cardiovascular R&D \nSekar Kathiresan\, CEO\, Verve Therapeutics Michael Mendelsohn\, Founder & Chairman\, Cardurion Pharmaceuticals Christopher de Souza\, Director\, Broadview Ventures Claudia Ulbrich\, CEO & Co-Founder\, Cardior Pharmaceuticals Session Leader: Simone Fishburn\, VP & Editor in Chief\, BioCentury Inc. \n10:15 Reaching the Next Frontiers in Cancer Therapies Rajesh Chopra\, Venture Partner\, Head of Oncology\, Apple Tree Partners Adam Friedman\, President\, Corporate Strategy & Business Development\, Scorpion Therapeutics Luba Greenwood\, CEO\, Kojin Therapeutics KT Moortgat\, Healthcare Venture Investor\, Investment Partner\, Droia Ventures Lewis Williams\, Co-founder\, Chairman & CEO\, Walking Fish Therapeutics\, Inc. \nSession Leader: Dave Madge\, VP of Discovery Services\, WuXi AppTec \n11:00 Day 2 Adjourn \nDay 3\, April 28 \n8:00 Welcome & Opening Remarks \nJocelyne Bath\, Managing Director\, OXGENE Richard Connell\, SVP & US / EU COO\, WuXi AppTec \n8:10 Healthcare 2030: Current and Future Drivers of Success A conversation between William Hait\, EVP\, Chief External Innovation\, Medical Safety & Global Public Health Officer\, Johnson & Johnson\, and Julie Grant\, General Partner\, Canaan \n8:30 Spotlight on Singapore: The Asia-Pacific Translation Hub for Cell and Gene Therapy in Oncology Andrew Bruce\, CEO\, MediSix Therapeutics Wee Joo Chng\, Executive Director\, Singapore Translational Cancer Consortium; Director & Senior Consultant\, National University Cancer Institute\, Singapore\, NUHS Boon Tong Koh\, Executive Director\, Bioprocessing Technology Institute\, A*STAR\, Singapore Francesca Lim\, Assistant Medical Director\, Cell Therapy Facility\, Health Science Authority (HSA); Senior Consultant Hematologist\, Singapore General Hospital Yann Chong Tan\, Managing Director\, EVX Ventures; CEO\, Nuevocor; CSO\, Cargene Therapeutics Session Leader: Danny Soon\, CEO\, Consortium for Clinical Research & Innovation\, Singapore; Executive Director\, Singapore Clinical Research Institute \n9:30 Spotlight on UK: The Life Science Cluster Standing on the Shoulders of Giants Opening Remarks by Steve Bates\, CEO\, UK BioIndustry Association Billy Boyle\, Co-Founder & CEO\, Owlstone Medical Ryan Cawood\, CSO\, WuXi Advanced Therapies & OXGENE Kathryn Corzo\, COO\, bit.bio Jack O’Meara\, CEO\, Ochre Bio Session Leader: Michael Ward\, Global Head of Life Sciences & Healthcare Thought Leadership\, Clarivate \n10:30 When Technology Meets Healthcare \nVineeta Agarwala\, General Partner\, Andreessen Horowitz Rohit Chandra\, Chief Digital Officer\, Cleveland Clinic Daphne Koller\, CEO & Founder\, insitro Session Leader: Ben Robbins\, Venture Partner\, GV \n11:20 Forum Adjourn
URL:https://dev.califesciences.org/event/wuxi-healthcare-forum-2022/
LOCATION:Virtual
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/03/258762_CLS_22_Event_Graphics-13-450x254-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220425
DTEND;VALUE=DATE:20220427
DTSTAMP:20260407T094024
CREATED:20220225T014326Z
LAST-MODIFIED:20220331T205755Z
UID:6669-1650844800-1651017599@dev.califesciences.org
SUMMARY:Stanford Drug Discovery Symposium (SDDS)
DESCRIPTION:Location: Virtual \n  \nAdvances in research and technology now afford us the unique opportunity to develop and test novel diagnostics and therapeutics. This conference takes advantage of the collective experience and expertise of our participants to cover a broad range of policy\, research\, and venture topics. This symposium provides an invaluable forum for interdisciplinary exchange at the forefront of drug research. \n  \nRegister»
URL:https://dev.califesciences.org/event/stanford-drug-discovery-symposium-sdds/
LOCATION:Virtual
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-12.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220419T133000
DTEND;TZID=America/Los_Angeles:20220419T160000
DTSTAMP:20260407T094024
CREATED:20220418T165716Z
LAST-MODIFIED:20220419T164645Z
UID:8023-1650375000-1650384000@dev.califesciences.org
SUMMARY:UCLA TDG - So You Have A Great Idea What's Next?
DESCRIPTION:The UCLA Postdoctoral Association is delighted to announce together with the Danforth Advisors and the UCLA Technology Development Group this in person event “So You Have A Great Idea What’s Next?” \nApril Pyle PhD | UCLA Broad Stem Cell Center; Pyle Lab at UCLA & co-founder MyoGene Bio \nBarbara Alcaraz Silva PhD  – Silicon Valley Bank \nAndy Kadlec\, M.D.\, Ph.D.– Vida Ventures \nMatt Hallinan JD – Cooley \n  \nPDA-TDG-DAdv \nRegister»
URL:https://dev.califesciences.org/event/ucla-tdg-so-you-have-a-great-idea-whats-next/
LOCATION:UCLA\, Boyer Hall 611 Charles E Young Dr E\, Los Angeles\, CA\, 90095\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220412
DTEND;VALUE=DATE:20220415
DTSTAMP:20260407T094024
CREATED:20220225T013713Z
LAST-MODIFIED:20220331T204806Z
UID:6665-1649721600-1649980799@dev.califesciences.org
SUMMARY:Informa: MD&M West
DESCRIPTION:Location: Anaheim Convention Center \n  \nMD&M West is the leading medical device technology and innovation event in the US\, attracting thousands of engineers\, founders and buyers each year in Anaheim\, California. MD&M West is part of IME West\, representing all facets of advanced manufacturing including medical plastics\, packaging\, automation\, prototyping and much more. The three-day expo features more than 1\,500 exhibiting companies plus many conference and networking opportunities. \n  \nRegister»
URL:https://dev.califesciences.org/event/mdm-west/
LOCATION:Anaheim Convention Center\, Anaheim\, CA\, United States
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-14.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220329T113000
DTEND;TZID=America/Los_Angeles:20220329T121500
DTSTAMP:20260407T094024
CREATED:20220301T004358Z
LAST-MODIFIED:20220301T212752Z
UID:6736-1648553400-1648556100@dev.califesciences.org
SUMMARY:National Life Science Startup Symposium - "FDA For Life Science Companies: The Insiders Guide to FDA Approval"
DESCRIPTION:Kwame Ulmer is a 12 year veteran of the FDA and currently works as a regulatory strategist and investor. You will learn how to develop a regulatory strategy\, maximize your interactions with the FDA and efficiently get your product approved. The presentation is geared towards helping C-Suite executives understand the key levers to drive premarket approval and compliance attractive to investors. The presentation will also discuss overcoming the regulatory challenges during COVID.
URL:https://dev.califesciences.org/event/national-life-science-startup-symposium-fda-for-life-science-companies-the-insiders-guide-to-fda-approval/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13-450x254-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220329
DTEND;VALUE=DATE:20220401
DTSTAMP:20260407T094024
CREATED:20220219T000027Z
LAST-MODIFIED:20220331T204215Z
UID:6514-1648512000-1648771199@dev.califesciences.org
SUMMARY:Pismo Ventures: National Life Science Startup Symposium
DESCRIPTION:Location: Virtual \nWe are excited to announce the upcoming National Life Science Startup Symposium on March 29th and 31st. This is a Pismo Ventures Event\, sponsored and presented by The George Washington University and The Society of Physician Entrepreneurs. \nThe website event is: https://lifescience.startupsymposium.com and the Registration Deadline is March 13\, 2022. \nAs members of the organizing committee\, we would like to invite startups to participate in the Symposium. Startup participants have a tremendous opportunity to be seen by hundreds of investors across the country\, and have a chance of being funded by the participating investors.\nThis is our third Symposium. At the last two Symposiums\, we had over 200 startups participating. We also had (and will have for this Symposium) about 150+ Angel investors and 50+ VCs who judge the startup pitches. This dynamic provides tremendous value to both the startups and the investors. The startups get exposures to numerous potential investors\, and the investors get an excellent deal flow to evaluate. A few startups from our previous Symposiums got the attention of the judges/investors and received significant investments subsequently\, e.g. via SPV’s and/or direct angel/VC investments. \nIn addition to providing this opportunity to be seen by a large number of investors\, the Symposium includes the following valuable panels and webinars. \nPanels:\n“Working with University Tech Transfer for Startups”\n“Partnering with Big Pharma\, Diagnostic\, and MedTech Companies for Startups” \nWebinars:\n“Structuring your Startup and Negotiating Financing”\n“FDA For Life Science Companies: The Insiders Guide to FDA Approval” \nWe have already confirmed participation from the following organizations\, and are expecting many more: \n\nGeorge Washington University\nGeorgetown University\nArizona State University\nUniversity of Arizona\nUniversity of California Irvine\nUniversity of California Berkeley\n\nNote: FREE registration for all applicants. \nWe are sure that it will be a great event to increase visibility for startups and also provide them with valuable information and contacts. \nRegister»
URL:https://dev.califesciences.org/event/national-life-science-startup-symposium/
LOCATION:Virtual
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220325T080000
DTEND;TZID=America/Los_Angeles:20220325T090000
DTSTAMP:20260407T094024
CREATED:20220310T224234Z
LAST-MODIFIED:20220310T224337Z
UID:6894-1648195200-1648198800@dev.califesciences.org
SUMMARY:Halloran Town Hall: Total Data Control and Custody – Moving from Excel to Complete Integration for Better Clinical Trial Decisions
DESCRIPTION:We have certainly come a long way in clinical trial operations over the past few years as our industry collectively shifted to decentralized and hybrid models to collect patient data outside of the traditional site model. And sponsors have a lot of data. This growth\, though celebrated\, also comes with growing pains\, like figuring how to build a large data mapping infrastructure to harness the trial’s data for better insight and oversight. \nIf you’re experiencing a similar issue\, please join our Halloran-hosted virtual Town Hall on March 25\, 2022\, from 11:00a.m. – 12:00p.m. EST on “Total Data Control and Custody: Moving from Excel to Complete Integration for Better Clinical Trial Decisions” led by the global data strategy and innovation team at CSL Behring and joined by experts from Halloran. CSL Behring has recently designed a data infrastructure for their studies that allowed their teams to have better control over their data\, leading to more informed decisions. They have major lessons learned and context behind their change and will be sharing their insights with the panel (and you!) to work through the following: \nHow do you integrate data sources and automate processes to get to a point of total data control regardless of company size? \nHow to get executive buy-in around data standards and oversight? \nWhat does the planning entail? Where do we start? \nIs this the future of data? How should companies prepare? \nIf you too want to evolve in this direction\, there is significant time and money that will need to be spent well in advance of when the trial data needs to be submitted. So\, let’s brainstorm and learn from each other. We hope you can join us – and bring your questions – to talk through scenarios for better data strategy\, control\, and custody for better decision making. \nMeet the Panel: \nMeghan Powers\, Director\, Clinical Practice Operations\, Halloran Consulting Group; Karen Travers\, Associate Principal Consultant\, Organizational & Quality Solutions\, Halloran Consulting Group; Thomas Verish\, Head of Global Data Strategy & Innovation\, CSL Behring; Valerie Reynaert\, Head of Global Clinical Operations\, CSL Behring; Charles Johnson\, Director\, eClinical Operations\, CSL Behring; Tony Ciliberto\, Senior Director\, Global Clinical Operations\, CSL Behring \nRegister» \nUpon registration you will receive a calendar invite with Zoom info.
URL:https://dev.califesciences.org/event/halloran-town-hall-total-data-control-and-custody-moving-from-excel-to-complete-integration-for-better-clinical-trial-decisions/
LOCATION:Live\, Online
CATEGORIES:Industry Supported,Member Events
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-12.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220316T110000
DTEND;TZID=America/Los_Angeles:20220316T113000
DTSTAMP:20260407T094024
CREATED:20220302T234427Z
LAST-MODIFIED:20220304T001319Z
UID:6766-1647428400-1647430200@dev.califesciences.org
SUMMARY:Using STEP and SciLeads To Grow Your California Biotech Business
DESCRIPTION:Join the live webinar with Laura Haldane as she introduces SciLeads\, an innovative life science and applied research lead generation platform. SciLeads works with bioscience companies in California and around the world to accelerate their sales by enabling them to quickly find and engage with targeted and funded leads\, and develop outreach strategies. \nAlso joining Laura is Mariana Guevara from the California Governor’s Office of Business and Economic Development who will speak about how the STEP grant program can contribute toward the cost of the SciLeads database subscription. \nRegister»
URL:https://dev.califesciences.org/event/using-step-and-scileads-to-grow-your-california-biotech-business/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/03/258762_CLS_22_Event_Graphics-13-450x254-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220315T073000
DTEND;TZID=America/Los_Angeles:20220315T170000
DTSTAMP:20260407T094024
CREATED:20220218T232315Z
LAST-MODIFIED:20220225T000143Z
UID:6502-1647329400-1647363600@dev.califesciences.org
SUMMARY:Fierce Pharma: BD&L Summit - Deal-Making Insights for the Life Sciences Industry
DESCRIPTION:Successfully identify and execute strategic partnerships\, licensing\, and M&A Deals \nThe Fierce Business Development and Licensing (BD&L) Summit for Life Sciences returns LIVE in 2022 bringing together key deal-makers and serving as an open forum for cross-functional business development\, due diligence\, finance\, and legal teams to share valuable insights and actionable strategies on successfully sourcing and evaluating new opportunities\, conducting due diligence\, and structuring licensing agreements and M&A deals. \nCLS Members receive 25% off your registration using code CALS at checkout!  \nRegister»
URL:https://dev.califesciences.org/event/bdl-summit-deal-making-insights-for-the-life-sciences-industry/
LOCATION:Hyatt Centric Fisherman’s Wharf San Francisco\, 555 North Point Street\, San Francisco\, 94133\, United States
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-14.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220309
DTEND;VALUE=DATE:20220311
DTSTAMP:20260407T094024
CREATED:20220224T234342Z
LAST-MODIFIED:20220225T163553Z
UID:6644-1646784000-1646956799@dev.califesciences.org
SUMMARY:MDMA: 2022 FDA Forum
DESCRIPTION:MDMA’s 2022 FDA Forum will feature senior officials from FDA and industry and focus on the\nkey regulatory issues impacting the medical device industry. \nDesigned specifically for medical device regulatory professionals and executive decision makers\,\nMDMA’s FDA Forum promises to deliver key regulatory insights and preview trends\nthat will impact your regulatory and business strategies. \nTopics will include: \nFDA’s Continued COVID-19 Response\nNavigating 510(k)\, De Novo\, PMA Programs\nDigital Health\nCDRH Update\nBest Practices for Pre-Submission meetings\nEmerging Issues (Biocompatibility\, Supply Chain & More)\nMDUFA Update \nThis conference is pre-approved by RAPS as eligible for up to 6 credits towards a participant’s RAC recertification upon full completion \nCLS Members receive $100 off registration using code STATE at checkout.  \n  \nRegister»
URL:https://dev.califesciences.org/event/mdma-2022-fda-forum/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220222T160000
DTEND;TZID=America/Los_Angeles:20220222T180000
DTSTAMP:20260407T094024
CREATED:20220218T174339Z
LAST-MODIFIED:20220225T170324Z
UID:6479-1645545600-1645552800@dev.califesciences.org
SUMMARY:Women in Bio - SoCal Chapter Presents "Rare Disease 8: Intersecting Access & Diversity for Underserved Communities"
DESCRIPTION:Join us for a discussion on improving patient access to healthcare in under-represented communities\, the importance of diversifying clinical trials\, and exploring rare diseases that affect Black\, Indigenous\, and People of Color (BIPOC) women. \nRegister»
URL:https://dev.califesciences.org/event/women-in-bio-socal-chapter-presents-rare-disease-8-intersecting-access-diversity-for-underserved-communities/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-15.jpg
END:VEVENT
END:VCALENDAR